Lineage Cell Therapeutics (LCTX) Tax Rate (2019)
Lineage Cell Therapeutics' Tax Rate came in at 7.69% for FY2025.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Tax Rate (2019) Analysis & Trends
Going back to FY2018, Lineage Cell Therapeutics' Tax Rate data covers 6 years.
- Tax Rate carries a five-year change of +2.04 percentage points (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual Tax Rate since FY2022.
- Per Business Quant, earlier years put Tax Rate at 7.74% in FY2023 (+9.84 pp) and -2.10% in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.98% |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | - |
API Access
Lineage Cell Therapeutics Tax Rate API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-rate&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-rate", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-rate&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();